The only significant difference between non-malignant lesions and other prostate conditions was comparing the proportion of PD1+CD8+ T-cells, which was decreased in BPH (median 64.8% vs. 36.1% p = 0.004) (Figure 4A–4C). The gene discussed is PDCD1; the disease is benign prostatic hyperplasia.